Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A tripartite mechanism licenses RNA polymerase import into the phage nucleus. | bioRxiv | 2026 | 42818118 | PubTator, text mining | PubMed |
| IGF2BP1-Mediated m6A Modification Enhances the Stability of circ_0088302 to Promote Gastric Cancer Progression. | Adv Biol (Weinh) | 2026 | 42802600 | PubTator, text mining | PubMed |
| IGF2BP1: a double agent in hemoglobin switching. | Blood | 2026 | 42783360 | PubTator, text mining | PubMed |
| Epitranscriptomic stabilization of PGRMC1 by the METTL3-IGF2BP1 axis promotes ovarian cancer progression. | Cell Signal | 2026 | 42777928 | PubTator, text mining | PubMed |
| H3K18la facilitates nasopharyngeal carcinoma progression through the activation of the IGF2BP1-COX2 signaling pathway. | Front Immunol | 2026 | 42774366 | PubTator, text mining | PubMed |
| Stress granule phase transitions and neuronal fate in cerebral ischemia-reperfusion injury. | Front Mol Neurosci | 2026 | 42769600 | PubTator, text mining | PubMed |
| [Preliminary exploration of BBOX1-AS1 as a potential biomarker involved in the regulation of tumor cell proliferation in non-small cell lung cancer]. | Zhonghua Zhong Liu Za Zhi | 2026 | 42764220 | PubTator, text mining | PubMed |
| Epitranscriptomic Regulation of Cardiac Ischemia-Reperfusion Injury: Unveiling the METTL14/IGF2BP1/PDE4D Axis. | Korean Circ J | 2026 | 42750131 | PubTator, text mining | PubMed |
| Helicobacter pylori-Induced Persistent IGF2BP1 Activation Promotes Ferroptosis Resistance in Gastric Tumorigenesis. | Adv Sci (Weinh) | 2026 | 42725716 | PubTator, text mining | PubMed |
| Mapping Allele-specific RBP Binding by a Machine Learning Coupled RNA Editing Strategy in Human Embryonic Stem Cells. | Genomics Proteomics Bioinformatics | 2026 | 42671340 | PubTator, text mining | PubMed |
| HDAC2 restrains IGF2BP1-associated m6A dysregulation in cervical cancer immunotherapy resistance. | PLoS One | 2026 | 42658872 | PubTator, text mining | PubMed |
| A human stem cell model of neuroblastoma identifies four chromosome 17q genes that drive tumor initiation and progression. | Cancer Lett | 2026 | 42648464 | PubTator, text mining | PubMed |
| ZBTB33/RBM15 Axis Upregulates MACC1 to Promote the Malignant Progression of Colorectal Cancer. | Curr Gene Ther | 2026 | 42634545 | PubTator, text mining | PubMed |
| Benzo[a]pyrene-induced METTL3 overexpression accelerates renal cell carcinoma progression via m6A modification of LTB4R mRNA and enhanced Treg infiltration. | Ecotoxicol Environ Saf | 2026 | 42628180 | PubTator, text mining | PubMed |
| Comprehensive Analysis of m6A Regulators Identifies YTHDF3 as a Promising Prognostic Biomarker for Breast Cancer. | J Vis Exp | 2026 | 42612048 | PubTator, text mining | PubMed |
| PCAT6 Regulates IGF2BP1/PD-L1 to Promote Immune Escape in Breast Cancer. | J Gene Med | 2026 | 42581605 | PubTator, text mining | PubMed |
| Exosome-delivered miR-769-3p promotes malignant progression of hepatocellular carcinoma via ALKBH5-dependent m6A modification. | Hepatobiliary Pancreat Dis Int | 2026 | 42575732 | PubTator, text mining | PubMed |
| Ferroptosis Suppression by the M6A Reader IGF2BP1 Underlies Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. | Adv Sci (Weinh) | 2026 | 42573560 | PubTator, text mining | PubMed |
| Exploring the BICC1 Interactome in HEK293T Cells: Insights Into RNA-Mediated Protein Networks and Biomolecular Condensates. | FASEB Bioadv | 2026 | 42569767 | PubTator, text mining | PubMed |
| The N6-Methyladenosine-Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. | Immunol Cell Biol | 2026 | 42565639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers